Company intelligence / Profile preview

Telperian

Solana Beach, California, United Statestelperian.com ↗

Ownership: Private
Development stage: Other

Overview

Telperian offers advanced machine learning and biostatistics platforms to optimize clinical trial design, analysis, and reporting. Their solutions are used by leading biopharma companies and cancer research centers to improve efficiency in drug development across multiple disease areas including oncology, autoimmune diseases, and neurological conditions. The company’s platform has been applied to real-world datasets with peer-reviewed methodologies but does not itself sponsor or conduct clinical trials of therapeutics.

Therapeutic areas: OncologyImmunologyNeurology
Industry: Drug Discovery Services

Partnerships

Leading biopharma companies and cancer research centers use their solutions (no specific partnerships named)

Beyond the preview

Go deeper on Telperian.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telperian.

Explore the full profile